Nxstage Medical (NXTM) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
NxStage Medical (NXTM) PT Lowered to $33 at Jefferies
May 10, 2017 9:55 AM EDTJefferies lowered its price target on NxStage Medical (NASDAQ: NXTM) to $33.00 (from $38.00) while maintaining a Buy rating.
NXTM had endorsed an outlook that called for sales to increase from $366mn in 2016 to $700mn in 2020, a CAGR of +18%. Management hasnt changed its... More
NxStage Medical (NXTM) PT Lowered to $30 at Canaccord Genuity
May 10, 2017 8:54 AM EDTCanaccord Genuity lowered its price target on NxStage Medical (NASDAQ: NXTM) to $30.00 (from $32.00) while maintaining a Buy rating. NxStage reported 1Q results with revenue of $96.8M above the Street's expectations of $95.3M. EPS came in at $(0.02) and was in line with consensus... More
